Haijiang Wang
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 5
- Molecular Biology top 10%
- Circular RNAs in diseases 5
-
- Colorectal Cancer Surgical Treatments 7
-
- Gastric Cancer Management and Outcomes 12
- Metastasis and carcinoma case studies 5
-
- Colorectal and Anal Carcinomas 6
-
- Gastrointestinal Tumor Research and Treatment 4
- Co-authors
- Quanbo ZhouJinbo LiuGuixian WangWeitang YuanWeiwei WangZhenqiang SunLiang MingYangxia Wang
- Partner nations
- ChinaBelgiumUnited States
In The Last Decade
Haijiang Wang
49 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Cancer Research 924
- Molecular Biology 1.1k
- Oncology 221
- Geriatrics and Gerontology 20
- Immunology 107
Countries citing papers authored by Haijiang Wang
This map shows the geographic impact of Haijiang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haijiang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haijiang Wang more than expected).
Fields of papers citing papers by Haijiang Wang
This network shows the impact of papers produced by Haijiang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haijiang Wang. The network helps show where Haijiang Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Haijiang Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 1 | |
| 4 | 2022 | 5 | |
| 5 | 2022 | 2 | |
| 6 | 2021 | 4 | |
| 7 | 2021 | 0 | |
| 8 | 2020 | 7 | |
| 9 | 2020 | 3 | |
| 10 | 2019 | 323 | |
| 11 | Exosomal circRNAs: biogenesis, effect and application in human diseasesbreakdown → | 2019 | 504 |
| 12 | 2018 | 12 | |
| 13 | 2017 | 26 | |
| 14 | 2017 | 2 | |
| 15 | 2016 | 6 | |
| 16 | 2015 | 33 | |
| 17 | 2015 | 37 | |
| 18 | 2015 | 10 | |
| 19 | 2014 | 15 | |
| 20 | Ultrasonographic observation on characteristics of the lymph node metastases of primary pancreatic cancer in draining regions | 2010 | 1 |
About Haijiang Wang
Haijiang Wang is a scholar working on Gastroenterology, Cancer Research and Oncology, having authored 51 papers that have together received 1.5k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (12 papers), Colorectal Cancer Surgical Treatments (7 papers), Colorectal and Anal Carcinomas (6 papers), Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (5 papers), Metastasis and carcinoma case studies (5 papers), Circular RNAs in diseases (5 papers) and Gastrointestinal Tumor Research and Treatment (4 papers). The work is most often cited by research in Cancer Research (924 citations), Molecular Biology (1.1k citations) and Oncology (221 citations). Haijiang Wang has collaborated with scholars based in China, Belgium and United States. Frequent co-authors include Quanbo Zhou, Jinbo Liu, Guixian Wang, Weitang Yuan, Weiwei Wang, Zhenqiang Sun, Liang Ming, Yangxia Wang, Ting Sun and Jiang Li. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.